MedKoo Cat#: 571777 | Name: SUN 06690
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

SUN 06690, also known as N-(t-butyl ester-PEG2)-N-bis(PEG2-propargyl) is a branched alkyne PEG Linker. PEG Linkers may be useful in the development of antibody drug conjugates and drug delivery methods. This product has no formal name at the moment. For the convenience of communication, a temporary code name was therefore proposed according to MedKoo Chemical Nomenclature (see web page: https://www.medkoo.com/page/naming).

Chemical Structure

SUN 06690
SUN 06690
CAS# 2100306-69-0

Theoretical Analysis

MedKoo Cat#: 571777

Name: SUN 06690

CAS#: 2100306-69-0

Chemical Formula: C25H43NO8

Exact Mass: 485.2989

Molecular Weight: 485.62

Elemental Analysis: C, 61.83; H, 8.93; N, 2.88; O, 26.36

Price and Availability

Size Price Availability Quantity
100mg USD 650.00
250mg USD 1,050.00
500mg USD 1,500.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
N-(t-butyl ester-PEG2)-N-bis(PEG2-propargyl); SUN 06690;SUN-06690; SUN06690
IUPAC/Chemical Name
tert-butyl 10-(2-(2-(prop-2-yn-1-yloxy)ethoxy)ethyl)-4,7,13,16-tetraoxa-10-azanonadec-18-ynoate
InChi Key
SNTDJGZACCWQRM-UHFFFAOYSA-N
InChi Code
InChI=1S/C25H43NO8/c1-6-12-28-18-21-31-15-9-26(10-16-32-22-19-29-13-7-2)11-17-33-23-20-30-14-8-24(27)34-25(3,4)5/h1-2H,8-23H2,3-5H3
SMILES Code
C#CCOCCOCCN(CCOCCOCCC(OC(C)(C)C)=O)CCOCCOCC#C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 485.62 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Zhu J, Hou B, Rong H, Xu K, Jiang L, Yang S, Zhu H, Yang H, Jiao Y, Liu Y, Ni K, Ma Z. Blocking brown adipocyte β3-adrenoceptor attenuates blood- spinal cord barrier impairment and chronic postsurgical pain in a rat model of preoperative stress. Int Immunopharmacol. 2024 Feb 15;128:111530. doi: 10.1016/j.intimp.2024.111530. Epub 2024 Jan 25. PMID: 38278068. 2: Kamal MM, El-Abhar HS, Abdallah DM, Ahmed KA, Aly NES, Rabie MA. Mirabegron, dependent on β3-adrenergic receptor, alleviates mercuric chloride-induced kidney injury by reversing the impact on the inflammatory network, M1/M2 macrophages, and claudin-2. Int Immunopharmacol. 2024 Jan 5;126:111289. doi: 10.1016/j.intimp.2023.111289. Epub 2023 Nov 27. PMID: 38016347. 3: Wu S, Ootawa T, Sekio R, Smith H, Islam MZ, Uno Y, Shiraishi M, Miyamoto A. Involvement of beta3-adrenergic receptors in relaxation mediated by nitric oxide in chicken basilar artery. Poult Sci. 2023 Jun;102(6):102633. doi: 10.1016/j.psj.2023.102633. Epub 2023 Mar 8. PMID: 37001317; PMCID: PMC10070147. 4: Lim I, Chess-Williams R. Mirabegron attenuates porcine ureteral contractility via α1-adrenoceptor antagonism. Naunyn Schmiedebergs Arch Pharmacol. 2022 Jul;395(7):839-847. doi: 10.1007/s00210-022-02244-0. Epub 2022 Apr 21. PMID: 35445849; PMCID: PMC9192402. 5: Ozveren Adibelli E, Aydinoglu F, Ogulener N. The role of l-cysteine/Hydrogen sulfide pathway on β3-Adrenoceptor- induced relaxation in mouse gastric fundus. Nitric Oxide. 2022 Feb 1;119:19-28. doi: 10.1016/j.niox.2021.12.004. Epub 2021 Dec 10. PMID: 34902580. 6: Schena G, Carmosino M, Chiurlia S, Onuchic L, Mastropasqua M, Maiorano E, Schena FP, Caplan MJ. β3 adrenergic receptor as potential therapeutic target in ADPKD. Physiol Rep. 2021 Oct;9(20):e15058. doi: 10.14814/phy2.15058. PMID: 34676684; PMCID: PMC8531837. 7: Pasha A, Calvani M, Favre C. β3-Adrenoreceptors as ROS Balancer in Hematopoietic Stem Cell Transplantation. Int J Mol Sci. 2021 Mar 11;22(6):2835. doi: 10.3390/ijms22062835. PMID: 33799536; PMCID: PMC8000316. 8: Modzelewska B, Jóźwik M, Kleszczewski T, Sulkowski S, Jóźwik M. Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies. Gynecol Obstet Invest. 2021;86(1-2):162-169. doi: 10.1159/000513718. Epub 2021 Feb 26. PMID: 33640886. 9: Pini A, Fazi C, Nardini P, Calvani M, Fabbri S, Guerrini A, Forni G, La Marca G, Rosa AC, Filippi L. Effect of Beta 3 Adrenoreceptor Modulation on Patency of the Ductus Arteriosus. Cells. 2020 Dec 7;9(12):2625. doi: 10.3390/cells9122625. PMID: 33297453; PMCID: PMC7762377. 10: Zhang H, Liu M, Kim HT, Feeley BT, Liu X. Preconditioning improves muscle regeneration after ischemia-reperfusion injury. J Orthop Res. 2021 Sep;39(9):1889-1897. doi: 10.1002/jor.24909. Epub 2020 Nov 24. PMID: 33232533; PMCID: PMC9257970. 11: Lippiello P, Hoxha E, Cristiano C, Malvicini E, Stanley A, Russo R, Tempia F, Miniaci MC. Role of β3-adrenergic receptor in the modulation of synaptic transmission and plasticity in mouse cerebellar cortex. J Neurosci Res. 2020 Nov;98(11):2263-2274. doi: 10.1002/jnr.24712. Epub 2020 Aug 17. PMID: 33174240. 12: Oiwa Y, Oka K, Yasui H, Higashikawa K, Bono H, Kawamura Y, Miyawaki S, Watarai A, Kikusui T, Shimizu A, Okano H, Kuge Y, Kimura K, Okamatsu-Ogura Y, Miura K. Characterization of brown adipose tissue thermogenesis in the naked mole-rat (Heterocephalus glaber), a heterothermic mammal. Sci Rep. 2020 Nov 10;10(1):19488. doi: 10.1038/s41598-020-74929-6. PMID: 33173084; PMCID: PMC7656259. 13: Calvani M, Dabraio A, Subbiani A, Buonvicino D, De Gregorio V, Ciullini Mannurita S, Pini A, Nardini P, Favre C, Filippi L. β3-Adrenoceptors as Putative Regulator of Immune Tolerance in Cancer and Pregnancy. Front Immunol. 2020 Sep 2;11:2098. doi: 10.3389/fimmu.2020.02098. PMID: 32983164; PMCID: PMC7492666. 14: Tjandra PM, Paralkar MP, Osipov B, Chen YJ, Zhao F, Ripplinger CM, Christiansen BA. Systemic bone loss following myocardial infarction in mice. J Orthop Res. 2021 Apr;39(4):739-749. doi: 10.1002/jor.24867. Epub 2020 Oct 6. PMID: 32965732; PMCID: PMC8218775. 15: Yoshioka Y, Negoro R, Kadoi H, Motegi T, Shibagaki F, Yamamuro A, Ishimaru Y, Maeda S. Noradrenaline protects neurons against H2 O2 -induced death by increasing the supply of glutathione from astrocytes via β3 -adrenoceptor stimulation. J Neurosci Res. 2021 Feb;99(2):621-637. doi: 10.1002/jnr.24733. Epub 2020 Sep 20. PMID: 32954502. 16: Calvani M, Dabraio A, Bruno G, De Gregorio V, Coronnello M, Bogani C, Ciullini S, Marca G, Vignoli M, Chiarugi P, Nardi M, Vannucchi AM, Filippi L, Favre C. β3-Adrenoreceptor Blockade Reduces Hypoxic Myeloid Leukemic Cells Survival and Chemoresistance. Int J Mol Sci. 2020 Jun 12;21(12):4210. doi: 10.3390/ijms21124210. PMID: 32545695; PMCID: PMC7352890. 17: Calvani M, Bruno G, Dabraio A, Subbiani A, Bianchini F, Fontani F, Casazza G, Vignoli M, De Logu F, Frenos S, Filippi L, Favre C. β3-Adrenoreceptor Blockade Induces Stem Cells Differentiation in Melanoma Microenvironment. Int J Mol Sci. 2020 Feb 20;21(4):1420. doi: 10.3390/ijms21041420. PMID: 32093135; PMCID: PMC7073111. 18: Bhatiya S, Choudhury S, Gari M, Singh P, Shukla A, Garg SK. Myometrial Calcium and Potassium Channels Play a Pivotal Role in Chromium-Induced Relaxation in Rat Uterus: an In Vitro Study. Biol Trace Elem Res. 2020 Nov;198(1):198-205. doi: 10.1007/s12011-020-02041-x. Epub 2020 Feb 7. PMID: 32034680. 19: Calvani M, Subbiani A, Vignoli M, Favre C. Spotlight on ROS and β3-Adrenoreceptors Fighting in Cancer Cells. Oxid Med Cell Longev. 2019 Dec 14;2019:6346529. doi: 10.1155/2019/6346529. PMID: 31934266; PMCID: PMC6942895. 20: Turan Yücel N, Can ÖD, Demir Özkay Ü. Catecholaminergic and opioidergic system mediated effects of reboxetine on diabetic neuropathic pain. Psychopharmacology (Berl). 2020 Apr;237(4):1131-1145. doi: 10.1007/s00213-019-05443-5. Epub 2020 Jan 7. PMID: 31912189.